Psychedelic Compound-Based Drug Stock, Mind Medicine, Up 56% Last Week

March 11, 2024 at 14:29 PM EDT

The FDA has granted breakthrough designation to Mind Medicine's program for the treatment of generalized anxiety disorder.

Financial News